Quarterly report [Sections 13 or 15(d)]

Other current assets (Details)

v3.25.1
Other current assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Other current assets    
Research and development credits receivable $ 14,693 $ 12,929
Prepayments 7,475 10,033
Clinical materials   59
VAT receivable 1,777 1,599
Other current assets 3,349 3,170
Total $ 27,294 $ 27,790